MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Lo, Ting Fang ^a,b   Tsai, Wei Chung ^a,b   Chen, Shui Tein ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; METHIONINE ADENOSYLTRANSFERASE; METHIONINE ADENOSYLTRANSFERASE 2A; METHIONINE ADENOSYLTRANSFERASE 2B; MICRORNA; MICRORNA 21 3P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; ENZYME REGULATION; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAT2A GENE; MAT2B GENE; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PREDICTION; RNA SEQUENCE;

BERBERINE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LIVER NEOPLASMS; LUCIFERASES; METHIONINE ADENOSYLTRANSFERASE; MICROARRAY ANALYSIS; MICRORNAS; MUTAGENESIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84884754127     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075628     Document Type: Article

References (63)

1. Mato JM, Corrales FJ, Lu SC, Avila MA, (2002) S-Adenosylmethionine: a control switch that regulates liver function. The FASEB journal 16: 15-26.
2. Mato JM, Lu SC, (2007) Role of S-adenosyl-L-methionine in liver health and injury. Hepatology 45: 1306-1312.
3. Kotb M, Mudd SH, Mato JM, Geller AM, Kredich NM, et al. (1997) Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends in genetics: TIG 13: 51.
4. Mato JM, Alvarez L, Ortiz P, Pajares MA, (1997) S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther 73: 265-280.
5. LeGros HL Jr, Halim AB, Geller AM, Kotb M, (2000) Cloning, expression, and functional characterization of the beta regulatory subunit of human methionine adenosyltransferase (MAT II). J Biol Chem 275: 2359-2366.
6. Cai J, Mao Z, Hwang J-J, Lu SC, (1998) Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer research 58: 1444-1450.
7. Lu SC, Mato JM, (2008) S-Adenosylmethionine in cell growth, apoptosis and liver cancer. Journal of gastroenterology and hepatology 23: S73-S77.
8. Frau M, Tomasi ML, Simile MM, Demartis MI, Salis F, et al. (2012) Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. Hepatology 56: 165-175.
9. Huang Z-Z, Mao Z, Cai J, Lu SC, (1998) Changes in methionine adenosyltransferase during liver regeneration in the rat. American Journal of Physiology-Gastrointestinal and Liver Physiology 275: G14-G21.
10. Huang ZZ, Mato JM, Kanel G, Lu SC, (1999) Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat. Hepatology 29: 1471-1478.
11. Pañeda C, Gorospe I, Herrera B, Nakamura T, Fabregat I, et al. (2002) Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation. Hepatology 35: 1381-1391.
12. Garcea R, Daino L, Pascale R, Simile MM, Puddu M, et al. (1989) Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis. Cancer research 49: 1850-1856.
13. Martínez-Chantar ML, Corrales FJ, Martínez-Cruz A, García-Trevijano ER, Huang Z-Z, et al. (2002) Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. The FASEB journal 16: 1292-1294.
14. Yang H, Sadda MR, Li M, Zeng Y, Chen L, et al. (2004) S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl-xS. Hepatology 40: 221-231.
15. Martinez-Chantar ML, García-Trevijano ER, Latasa MU, Martín-Duce A, Fortes P, et al. (2003) Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma.
16. Liu Q, Wu K, Zhu Y, He Y, Wu J, et al. (2007) Silencing MAT2A gene by RNA interference inhibited cell growth and induced apoptosis in human hepatoma cells. Hepatology Research 37: 376-388.
17. Wang Q, Liu QY, Liu ZS, Qian Q, Sun Q, et al. (2008) Inhibition of hepatocelluar carcinoma MAT2A and MAT2beta gene expressions by single and dual small interfering RNA. J Exp Clin Cancer Res 27: 72.
18. Ramani K, Yang H, Xia M, Ara AI, Mato JM, et al. (2008) Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2β. Hepatology 47: 521-531.
19. Wang Q, Liu Q-Y, Liu Z-S, Qian Q, Sun Q, et al. (2008) Lentivirus mediated shRNA interference targeting MAT2B induces growth-inhibition and apoptosis in hepatocellular carcinoma. World journal of gastroenterology: WJG 14: 4633.
20. Amin A, Subbaiah T, Abbasi K, (1969) Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Canadian journal of microbiology 15: 1067-1076.
21. Kuo C-L, Chi C-W, Liu T-Y, (2004) The anti-inflammatory potential of berberine in vitro and in vivo. Cancer letters 203: 127-137.
22. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, et al. (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55: 2256-2264.
23. Sun Y, Xun K, Wang Y, Chen X, (2009) A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-cancer drugs 20: 757-769.
24. Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, et al. (2000) Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer letters 148: 19-25.
25. Mantena SK, Sharma SD, Katiyar SK, (2006) Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Molecular cancer therapeutics 5: 296-308.
26. Peng P-L, Hsieh Y-S, Wang C-J, Hsu J-L, Chou F-P, (2006) Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicology and applied pharmacology 214: 8-15.
27. Kim S, Choi JH, Kim JB, Nam SJ, Yang J-H, et al. (2008) Berberine suppresses TNF-α-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 13: 2975-2985.
28. Wang L, Cao H, Lu N, Liu L, Wang B, et al. (2013) Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells. PloS one 8: e56666.
29. Wang L, Liu L, Shi Y, Cao H, Chaturvedi R, et al. (2012) Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor. PloS one 7: e36418.
30. Liu B, Wang G, Yang J, Pan X, Yang Z, et al. (2011) Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes. PloS one 6: e21416.
31. Auyeung KK-W, Ko JK-S, (2009) Coptis chinensis inhibits hepatocellular carcinoma cell growth through nonsteroidal anti-inflammatory drug-activated gene activation. International journal of molecular medicine 24: 571-577.
32. Tang J, Feng Y, Tsao S, Wang N, Curtain R, et al. (2009) Berberine and Coptidis Rhizoma as novel antineoplastic. Journal of ethnopharmacology 126: 5-17.
33. Hwang J-M, Kuo H-C, Tseng T-H, Liu J-Y, Chu C-Y, (2006) Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Archives of toxicology 80: 62-73.
34. Wang N, Feng Y, Zhu M, Tsang CM, Man K, et al. (2010) Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. Journal of cellular biochemistry 111: 1426-1436.
35. Ma C, Tang K, Liu Q, Zhu R, Cao Z (2013) Calmodulin as a potential target by which berberine induce cell cycle arrest in human hepatoma Bel7402 cells. Chemical biology & drug design.
36. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
37. Hwang H, Mendell J, (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. British journal of cancer 94: 776-780.
38. Jansson MD, Lund AH (2012) MicroRNA and cancer. Molecular oncology.
39. Iorio MV, Croce CM, (2012) microRNA involvement in human cancer. Carcinogenesis 33: 1126-1133.
40. Guo H, Ingolia NT, Weissman JS, Bartel DP, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
41. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
42. Winter J, Jung S, Keller S, Gregory RI, Diederichs S, (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature cell biology 11: 228-234.
43. Azuma-Mukai A, Oguri H, Mituyama T, Qian ZR, Asai K, et al. (2008) Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proceedings of the National Academy of Sciences 105: 7964-7969.
44. Okamura K, Phillips MD, Tyler DM, Duan H, Chou YT, et al. (2008) The regulatory activity of microRNA* species has substantial influence on microRNA and 3′ UTR evolution. Nature structural & molecular biology 15: 354-363.
45. Goff LA, Davila J, Swerdel MR, Moore JC, Cohen RI, et al. (2009) Ago2 immunoprecipitation identifies predicted microRNAs in human embryonic stem cells and neural precursors. PLoS One 4: e7192.
46. Guo L, Lu Z, (2010) The fate of miRNA* strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule? PLoS One 5: e11387.
47. Okamura K, Chung W-J, Lai EC, (2008) The long and short of inverted repeat genes in animals: microRNAs, mirtrons and hairpin RNAs. Cell Cycle 7: 2840-2845.
48. Yang J-S, Phillips MD, Betel D, Mu P, Ventura A, et al. (2011) Widespread regulatory activity of vertebrate microRNA* species. Rna 17: 312-326.
49. Liu XY, Zhang L, Zhang Y, Yang JM, (2012) Roles of eEF-2 kinase in cancer. Chinese Medical Journal 125: 2908-2913.
50. Rodrigues AC, Li X, Radecki L, Pan YZ, Winter JC, et al. (2011) MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines. Biopharmaceutics & drug disposition 32: 355-367.
51. Yokoi T, Nakajima M, (2013) microRNAs as Mediators of Drug Toxicity. Annual review of pharmacology and toxicology 53: 377-400.
52. Martinez-Sanchez A, Murphy CL, (2013) MicroRNA Target Identification-Experimental Approaches. Biology 2: 189-205.
53. Betel D, Koppal A, Agius P, Sander C, Leslie C, (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome biology 11: R90.
54. Zhu M, Wang N, Tsao S-W, Yuen M-F, Feng Y, et al. (2011) Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Experimental and Therapeutic Medicine 2: 27.
55. Hu HY, Li KP, Wang XJ, Liu Y, Lu ZG, et al. (2013) Set9, NF-kappaB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. Acta Pharmacol Sin 34: 157-166.
56. Braig S, Bosserhoff A, (2012) Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression. Oncogene 32: 837-848.
57. Venook AP, Papandreou C, Furuse J, de Guevara LL, (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. The Oncologist 15: 5-13.
58. Yang H, Huang Z-Z, Wang J, Lu SC, (2001) The role of c-Myb and Sp1 in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma. The FASEB journal 15: 1507-1516.
59. Rodriguez JL, Boukaba A, Sandoval J, Georgieva EI, Latasa MU, et al. (2007) Transcription of the MAT2A gene, coding for methionine adenosyltransferase, is up-regulated by E2F and Sp1 at a chromatin level during proliferation of liver cells. Int J Biochem Cell Biol 39: 842-850.
60. LeGros L, Halim AB, Chamberlin ME, Geller A, Kotb M, (2001) Regulation of the human MAT2B gene encoding the regulatory beta subunit of methionine adenosyltransferase, MAT II. J Biol Chem 276: 24918-24924.
61. Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer research 65: 7065-7070.
62. Molloy A (2011) Bioinformatic and Genetic Association Analysis of MicroRNA Target Sites in One-Carbon Metabolism Genes.
63. Yan GR, Xu SH, Tan ZL, Liu L, He QY, (2011) Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics. Proteomics 11: 912-920.